BioCardia, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
BioCardia, Inc. (BCDA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 9.40 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-03-24
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-12-31 was 80.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-09-30 was 2.35K shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2023-12-31 was -5.93K shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2022-12-31 was 0.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 9.40K shares, a 2121.51% increase from fiscal 2023.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 423.00 shares, a 86.40% decline from fiscal 2022.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 3.11K shares, a 2388.80% increase from fiscal 2021.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 125.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | 80.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 2.43K shares derived: sum of 2 quarters · filed 2026-03-24 | 9.40K shares 10-K · filed 2026-03-24 | ||
| 2024-09-30 | 2.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 9.32K shares 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | 6.96K shares 10-Q · filed 2024-08-13 | ||||
| 2023-12-31 | -5.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 423.00 shares 10-K · filed 2025-03-26 | 6.35K shares 10-K · filed 2024-03-27 | ||
| 2023-09-30 | 6.35K shares 10-Q · filed 2023-11-08 | ||||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-29 | 2.89K shares derived: sum of 3 quarters · filed 2023-03-29 | 3.11K shares 10-K · filed 2023-03-29 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 2.89K shares derived: sum of 2 quarters · filed 2022-11-09 | 3.11K shares 10-Q · filed 2022-11-09 | 3.11K shares derived: sum of 4 quarters · filed 2022-11-09 | |
| 2022-06-30 | 2.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 3.11K shares 10-Q · filed 2022-08-10 | 3.11K shares derived: sum of 3 quarters · filed 2022-08-10 | 3.11K shares derived: sum of 4 quarters · filed 2022-08-10 | |
| 2022-03-31 | 217.00 shares 10-Q · filed 2022-05-11 | 217.00 shares derived: sum of 2 quarters · filed 2022-05-11 | 217.00 shares derived: sum of 3 quarters · filed 2022-05-11 | 217.00 shares derived: sum of 4 quarters · filed 2022-05-11 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-29 | 0.00 shares derived: sum of 3 quarters · filed 2022-03-29 | 125.00 shares 10-K · filed 2022-03-29 | |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2021-11-10 | 125.00 shares 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 125.00 shares 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 125.00 shares 10-Q · filed 2021-05-13 | ||||
| 2016-09-30 | 305.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | 305.00K shares derived: sum of 2 quarters · filed 2016-10-17 | 305.00K shares 10-Q · filed 2016-10-17 | 305.00K shares derived: sum of 4 quarters · filed 2016-10-17 | |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | 0.00 shares 10-Q · filed 2016-08-02 | 0.00 shares derived: sum of 3 quarters · filed 2016-08-02 | 0.00 shares derived: sum of 4 quarters · filed 2016-08-02 | |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-03 | 0.00 shares derived: sum of 2 quarters · filed 2016-05-03 | 0.00 shares derived: sum of 3 quarters · filed 2016-05-03 | 0.00 shares derived: sum of 4 quarters · filed 2016-05-03 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-25 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-25 | 0.00 shares 10-K · filed 2016-03-25 | |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | 0.00 shares derived: sum of 2 quarters · filed 2015-10-29 | 0.00 shares 10-Q · filed 2015-10-29 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-25 | |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 0.00 shares 10-Q · filed 2015-08-12 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-25 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-25 | |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-12 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-25 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-25 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-25 | |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-25 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-25 | 0.00 shares 10-K · filed 2016-03-25 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2014-11-06 | 0.00 shares 10-Q · filed 2014-11-06 | 0.00 shares derived: sum of 4 quarters · filed 2014-11-06 | |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | 0.00 shares 10-Q · filed 2014-08-06 | 0.00 shares derived: sum of 3 quarters · filed 2014-08-06 | 0.00 shares derived: sum of 4 quarters · filed 2014-08-06 | |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-12 | 0.00 shares derived: sum of 2 quarters · filed 2014-05-12 | 0.00 shares derived: sum of 3 quarters · filed 2014-05-12 | 0.00 shares derived: sum of 4 quarters · filed 2014-05-12 | |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-24 | 0.00 shares derived: sum of 3 quarters · filed 2014-03-24 | 0.00 shares 10-K · filed 2014-03-24 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-01 | 0.00 shares 10-Q · filed 2013-11-01 | 0.00 shares derived: sum of 4 quarters · filed 2014-03-24 | |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | 0.00 shares 10-Q · filed 2013-07-26 | 0.00 shares derived: sum of 3 quarters · filed 2014-03-24 | 0.00 shares derived: sum of 4 quarters · filed 2014-03-24 | |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-10 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-24 | 0.00 shares derived: sum of 3 quarters · filed 2014-03-24 | ||
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-24 | 0.00 shares 10-K · filed 2014-03-24 | ||
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | 0.00 shares 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | 0.00 shares 10-Q · filed 2012-08-10 | ||||
| 2011-12-31 | -1.58M shares 10-K · filed 2013-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |